Survival outcomes in patients with multiple primary melanomas

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 11, 2015, Pages 2120-2127

  Rowe, C J ^a,b   Law, M H ^b   Palmer, J M ^b   Macgregor, S ^b   Hayward, N K ^b   Khosrotehrani, K ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRESLOW THICKNESS; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIPLE CANCER; MULTIPLE PRIMARY MELANOMA; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE INVASIVE PRIMARY MELANOMA; SURVIVAL TIME; YOUNG ADULT; ADOLESCENT; AGE; CHILD; EPIDEMIOLOGY; INFANT; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; QUEENSLAND; SECOND CANCER; SEX DIFFERENCE; SKIN TUMOR; SURVIVAL RATE; VERY ELDERLY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PROPORTIONAL HAZARDS MODELS; QUEENSLAND; RETROSPECTIVE STUDIES; SEX FACTORS; SKIN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84945446605     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13144     Document Type: Article

References (27)

1. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia: An Overview 2012. AIHW, Canberra, 2012.
2. Savoia P, Osella-Abate S, Deboli T, et al,. Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study. J Eur Acad Dermatol Venereol 2012; 26: 882-888.
3. Youlden DR, Youl PH, Soyer HP, Aitken JF, Baade PD,. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma in queensland, Australia, 1982-2010. JAMA Dermatol. 2014; 150: 526-534.
4. Balch CM, Gershenwald JE, Soong SJ, et al,. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-6206.
5. Kricker A, Armstrong BK, Goumas C, et al,. Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study. JAMA Dermatol 2013; 149: 921-927.
6. Doubrovsky A, Menzies SW,. Enhanced survival in patients with multiple primary melanoma. Arch Dermatol 2003; 139: 1013-1018.
7. Bower MR, Scoggins CR, Martin RC 2nd, et al,. Second primary melanomas: incidence and outcome. Am Surg 2010; 76: 675-681.
8. Burden AD, Vestey JP, Sirel JM, et al,. Multiple primary melanoma: risk factors and prognostic implications. BMJ 1994; 309: 375.
9. Murali R, Brown PT, Kefford RF, et al,. Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma. Cancer 2012; 118: 4519-4529.
10. Baxter AJ, Hughes MC, Kvaskoff M, et al,. The Queensland Study of Melanoma: environmental and genetic associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures. Twin Res Hum Genet 2008; 11: 183-196.
11. Frangos JE, Duncan LM, Piris A, et al,. Increased diagnosis of thin superficial spreading melanomas: a 20-year study. J Am Acad Dermatol 2012; 67: 387-394.
12. Mocellin S, Nitti D,. Cutaneous melanoma in situ: translational evidence from a large population-based study. Oncologist 2011; 16: 896-903.
13. R Core Team. R: a language and environment for statistical computing. Vienna, 2014.
14. Therneau TM,. A package for survival analysis in S. 2014. Version 2.37-7, http://CRAN.R-project.org/package=survival.
15. Ferrone CR, Ben Porat L, Panageas KS, et al,. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA 2005; 294: 1647-1654.
16. Gillgren P, Brattstrom G, Frisell J, et al,. Body site of cutaneous malignant melanoma-A study on patients with hereditary and multiple sporadic tumours. Melanoma Res 2003; 13: 279-286.
17. Hwa C, Price LS, Belitskaya-Levy I, et al,. Single versus multiple primary melanomas: old questions and new answers. Cancer 2012; 118: 4184-4192.
18. Weir HK, Johnson CJ, Thompson TD,. The effect of multiple primary rules on population-based cancer survival. Cancer Causes Control 2013; 24: 1231-1242.
19. Burden AD, Newell J, Andrew N, et al,. Genetic and environmental influences in the development of multiple primary melanoma. Arch Dermatol 1999; 135: 261-265.
20. Scheibner A, Milton GW, McCarthy WH, Norlund JJ, Pearson LJ,. Multiple primary melanoma-A review of 90 cases. Australas J Dermatol 1982; 23: 1-8.
21. Savoia P, Quaglino P, Verrone A, Bernengo MG,. Multiple primary melanomas: analysis of 49 cases. Melanoma Res 1998; 8: 361-366.
22. Green AC, Baade P, Coory M, Aitken JF, Smithers M,. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia. J Clin Oncol 2012; 30: 1462-1467.
23. Puntervoll HE, Yang XR, Vetti HH, et al,. Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. J Med Genet 2013; 50: 264-270.
24. Siskind V, Hughes MC, Palmer JM, et al,. Nevi, family history, and fair skin increase the risk of second primary melanoma. J Invest Dermatol 2011; 131: 461-467.
25. Joosse A, de Vries E, Eckel R, et al,. Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol 2011; 131: 719-726.
26. Joosse A, Collette S, Suciu S, et al,. Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials. J Clin Oncol 2012; 30: 2240-2247.
27. Gamba CS, Clarke CA, Keegan TH, Tao L, Swetter SM,. Melanoma survival disadvantage in young, non-Hispanic white males compared with females. JAMA Dermatol 2013; 149: 912-920.